-
3-Cysteinylacetaminophen TFA salt
- names:
S-[5-(acetylamino)-2-hydroxyphenyl]-L-cysteine, trifluoroacetate salt
- CAS号:
1331891-93-0
MDL Number: - MF(分子式): C13H15F3N2O6S MW(分子量): 384.33
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | 3-Cysteinylacetaminophen TFA salt |
| 英文别名 | APAP-Cys, 3-Cysteinylacetaminophen TFA salt, 3-(cysteine-S-yl)acetaminophen |
| CAS号 | 1331891-93-0 |
| Inchi | InChI=1S/C11H14N2O4S.C2HF3O2/c1-6(14)13-7-2-3-9(15)10(4-7)18-5-8(12)11(16)17;3-2(4,5)1(6)7/h2-4,8,15H,5,12H2,1H3,(H,13,14)(H,16,17);(H,6,7)/t8-;/m0./s1 |
| InchiKey | PDZGEXMJHANKLR-QRPNPIFTSA-N |
| 分子式 Formula | C13H15F3N2O6S |
| 分子量 Molecular Weight | 384.33 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | 3-Cysteinylacetaminophen TFA salt(CAS:1331891-93-0):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | 3-Cysteinylacetaminophen TFA salt is an acetaminophen-protein adduct formed during the metabolism of acetaminophen. In mice, 3-cysteinylacetaminophen decreases renal glutathione (GSH) levels --- an effect that can be blocked by the γ-glutamyl inhibitor acivicin. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Yoon, E., Babar, A., Choudhary, M., et al. Acetaminophen-induced hepatotoxicity: A comprehensive update. J. Clin. Transl. Hepatol. 4(2), 131-142 (2016).2. Stern, S.T., Bruno, M.K., Horton, R.A., et al. Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity II. Possible involvement of the γ-glutamyl cycle. Toxicol. Appl. Pharmacol. 202(2), 160-171 (2005).3. Heard, K., Green, J.L., Anderson, V., et al. Paracetamol (acetaminophen) protein adduct concentrations during therapeutic dosing. Br. J. Clin. Pharmacol. 81(3), 562-568 (2016).4. O'Malley, G.F., Mizrahi, F., Giraldo, P., et al. Protein-derived acetaminophen-cysteine can be detected after repeated supratherapeutic ingestion of acetaminophen in the absence of hepatotoxicity. J. Med. Toxicol. 11(3), 317-320 (2015). |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


